ATE127527T1 - Verfahren zur herstellung eines metastaseninhibitorenfaktors. - Google Patents

Verfahren zur herstellung eines metastaseninhibitorenfaktors.

Info

Publication number
ATE127527T1
ATE127527T1 AT90305459T AT90305459T ATE127527T1 AT E127527 T1 ATE127527 T1 AT E127527T1 AT 90305459 T AT90305459 T AT 90305459T AT 90305459 T AT90305459 T AT 90305459T AT E127527 T1 ATE127527 T1 AT E127527T1
Authority
AT
Austria
Prior art keywords
mif
producing
metastasis
hematopoietic cells
metastasis inhibitor
Prior art date
Application number
AT90305459T
Other languages
English (en)
Inventor
Masashi Kurimoto
Ryuichi Motoda
Kanso Iwaki
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Application granted granted Critical
Publication of ATE127527T1 publication Critical patent/ATE127527T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90305459T 1989-05-22 1990-05-21 Verfahren zur herstellung eines metastaseninhibitorenfaktors. ATE127527T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1128362A JP2926409B2 (ja) 1989-05-22 1989-05-22 癌転移抑制因子の製造方法

Publications (1)

Publication Number Publication Date
ATE127527T1 true ATE127527T1 (de) 1995-09-15

Family

ID=14982946

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90305459T ATE127527T1 (de) 1989-05-22 1990-05-21 Verfahren zur herstellung eines metastaseninhibitorenfaktors.

Country Status (11)

Country Link
US (1) US5126148A (de)
EP (1) EP0401997B1 (de)
JP (1) JP2926409B2 (de)
KR (1) KR0157227B1 (de)
AT (1) ATE127527T1 (de)
CA (1) CA2017279A1 (de)
DE (1) DE69022121T2 (de)
DK (1) DK0401997T3 (de)
ES (1) ES2080114T3 (de)
GR (1) GR3018004T3 (de)
RU (1) RU2070046C1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3439490B2 (ja) * 1992-09-28 2003-08-25 株式会社林原生物化学研究所 蛋白質とその蛋白質をコードするｄｎａ並びにその蛋白質の製造方法
JPH1080270A (ja) * 1996-07-19 1998-03-31 Hayashibara Biochem Lab Inc ポリペプチドをプロセッシングする酵素
CN1292073C (zh) * 1997-06-03 2006-12-27 森庸厚 天然抗肿瘤性或抗病毒性物质及其用途
RU2292875C2 (ru) * 2002-06-12 2007-02-10 Эйсай Ко., Лтд. Хиноновое терапевтическое средство для лечения заболевания печени

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785077A (en) * 1986-05-05 1988-11-15 Scripps Clinic And Research Foundation Substantially pure cytotoxicity triggering factor

Also Published As

Publication number Publication date
RU2070046C1 (ru) 1996-12-10
GR3018004T3 (en) 1996-02-29
CA2017279A1 (en) 1990-11-22
DK0401997T3 (da) 1995-10-16
JPH02308799A (ja) 1990-12-21
EP0401997A1 (de) 1990-12-12
KR0157227B1 (ko) 1998-10-15
EP0401997B1 (de) 1995-09-06
ES2080114T3 (es) 1996-02-01
DE69022121T2 (de) 1996-04-04
US5126148A (en) 1992-06-30
JP2926409B2 (ja) 1999-07-28
DE69022121D1 (de) 1995-10-12
KR900018379A (ko) 1990-12-21

Similar Documents

Publication Publication Date Title
DE60025015D1 (de) Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose
LV11783A (lv) Savienojumi un metodes megakariocitu augsanas un diferencesanas stimulesanai
DE69333433D1 (de) Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung
KR950700989A (ko) 사람 수지상 세포의 시험관내 생성방법 및 이의 용도(In vitro generation of human dendritic cells and uses thereof)
LU91498I2 (fr) Etanercept et ses dérivés pharmaceutiquement acceptables.
ATE174058T1 (de) Herstellung von proteinen mittels homologer rekombination
DE69133332D1 (de) Menschliche hematopoietische Stammzellen
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
EP0453453A4 (en) Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
DE69533941D1 (de) Verfahren zur herstellung eines arzneimittels zur behandlung des sekundärimmunmangels
BG35465A3 (en) Method for preparing derivatives of 1-(cyclohexyl)-4-aryl-4- piperidine carbonic acid
MY131053A (en) 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
ATE15693T1 (de) Zellkultur-verfahren.
ATE127527T1 (de) Verfahren zur herstellung eines metastaseninhibitorenfaktors.
MY131384A (en) Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
ATE5726T1 (de) Verfahren zur herstellung von antibiotikum c15003 p3.
ATE421573T1 (de) Verfahren zur herstellung von gamma delta t zellen
ATE21119T1 (de) Verfahren zur herstellung von 3-oxo-delta-1,4steroiden.
DE69013425D1 (de) Pseudomonasmutant, yzh-Stamm und Verfahren zur Herstellung der 851yzh-Nährlösung mittels dieses Stammes.
ES2000529A6 (es) Procedimiento para la obtencion de articulos moldeados de policarbonato cargado de hollin
ATE182365T1 (de) Verfahren zur herstellung von pilocarpin
ATE47427T1 (de) Verfahren zur herstellung von arphamenin mit hoher ausbeute.
DE3361506D1 (de) Preparing carbamic acid esters
SU722976A1 (ru) Среда дл закалки
DE3668166D1 (de) Verfahren zur herstellung von alkylarylethern.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee